Ajanta Pharma has informed that it enclosed the copy of the Annual Secretarial Compliance Report for year ended 31st March 2026 issued by D.G. Prajapati & Associates, Practicing Company Secretaries pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements), 2015.
The above information is a part of company’s filings submitted to BSE.